Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting No phase listed Observational

Cangrelor in Acute Myocardial Infarction: Effectiveness and Outcomes Registry

ClinicalTrials.gov ID: NCT04076813

Public ClinicalTrials.gov record NCT04076813. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 5:46 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this registry is to address optimal platelet inhibition during the early management of MI patients prior to coronary angiography or CABG.

Study identification

NCT ID
NCT04076813
Recruitment status
Active, not recruiting
Study type
Observational
Phase
Not listed
Lead sponsor
Chiesi USA, Inc.
Industry
Enrollment
5,050 participants

Conditions and interventions

Interventions

Not listed

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 15, 2019
Primary completion
Jun 29, 2025
Completion
Jun 29, 2025
Last update posted
Jun 12, 2025

2019 – 2025

United States locations

U.S. sites
11
U.S. states
11
U.S. cities
11
Facility City State ZIP Site status
The Regents of the University of California on behalf of its San Diego campus La Jolla California 92093
Christiana Care Health Services, Inc. Newark Delaware 19713
University of Florida Gainesville Florida 32611
Kootenai Hospital District dba Kootenai Health Coeur d'Alene Idaho 83814
MedStar Health Research Institute, Inc. Hyattsville Maryland 20782
The Brigham and Women's Hospital, Inc. Boston Massachusetts 02115
Henry Ford Health System Detroit Michigan 48202
Washington University St Louis Missouri 63110
The Trustees of Columbia University in the City of New York New York New York 10032
Duke University Durham North Carolina 27705
Vanderbilt University Medical Center Nashville Tennessee 37323

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04076813, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 12, 2025 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04076813 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →